9 results
Cardiogenic Shock Forrester Classification Table and Mortality

- Warm & Dry (Forrester Class I)

- Warm & Wet
Cardiogenic Shock ... Forrester Classification ... Table and Mortality ... #CHF #Diagnosis ... #Table #Cardiology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... #Pharmacology #Management ... #Therapy #Table ... #Overview
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Failure, Toxins/Medications ... Decompensated CHF ... #criticalcare #algorithm ... #treatment #management
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... Algorithm Lifestyle ... Rubella) • Medications ... #algorithm #DM2 ... #DMII #Classification
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... Infection/Sepsis/Shock ... Electrolyte abnormality, Medication ... the brain • CSF ... Syndrome #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... disease b) CHF ... ASA class If ... event, follow ACC algorithm ... medical and surgical management
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Heart Association class ... • Hypovolemic shock ... #Pharmacology #Medications ... #Table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
essentially Cardiogenic Shock ... #differential #algorithm ... #management #cardiology ... #treatment #table ... #heartfailure #chf
Indications for Implantable Cardioverter-Defibrillator (ICD) in Patients with Ischemic Heart Disease (IHD) to Prevent Sudden Cardiac
LVEF < 35%, NYHA class ... guideline-directed management ... LVEF < 30%, NYHA class ... management and ... unstable VT • Stable